Skip to content

SNYR

Synergy CHC Corp.

NASDAQ · Healthcare · Medical - Distribution · US

$0.10
−4.64%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 12, 2026
EPS estimate
$0.01
Revenue estimate
$9.0M

Latest reported

Last report date
Sep 3, 2026
EPS actual
-$0.01
EPS estimate
-$0.01
Revenue actual
$8.0M
Revenue estimate
$8.0M

Track record

Trailing twelve quarters

EPS beats (12Q)
2
EPS misses (12Q)
3
EPS in line (12Q)
3
Avg surprise (4Q)
-4116.7%
Revenue beats (12Q)
1
Earnings call summaryRead the full call →

Q4 FY2025 · Apr 1, 2026

AI summary of management’s prepared remarks and analyst Q&A · For informational purposes only, not investment advice

Management highlights

  • International license agreement: Licensee terminated the agreement covering UAE and Turkey, reversing $2.5 million licensing revenue in fourth quarter. Still view UAE and Turkey as attractive growth markets. - Mexico: Established wholly owned subsidiary in Mexico and initiated first product shipments to Costco Mexico in December. - Beverage division: Generated over $600,000 in gross revenue in first quarter of 2026, with millions of cans of RTEs and shots in stock; expect 2026 to be foundational growth year; have Costco and BJ's Roadshows planned. - Supplement side: Shipped three new SKUs to 1600 Kroger locations; TV advertising not restored in 2025, plan to restore in 2026 to drive same store growth.

Guidance

  • Anticipate gross margin to maintain or increase, excluding one - time items. - 2026 focus: Execute on restoring TV advertising to drive same - store growth in core supplement group; continue to grow beverage division with planned roadshows and distribution; further develop Mexico subsidiary's business.

Segment performance

Fourth quarter net revenue was $6.07 million compared to $10.27 million in the year - ago quarter, a 41% decrease. The decrease was due to the termination of the license agreement of $2.9 million. Without that reversal, net revenue was $8.97 million, a 12.7% decrease. Gross margin for the fourth quarter was 36.6% compared to 63.3% in the same quarter last year. For the full year of 2025, revenue was $30.38 million compared to $34.83 million in the year - ago period. Without reversing the $2.9 million in license revenue, net revenue would have been $33.28 million. Beverage division: In the first quarter of 2026, generated over $600,000 in gross revenue, surpassing the entire 2025 revenue, now equating to a $2.5 million run rate for 2026. Supplement side: Just shipped three new SKUs to all 1600 Kroger locations. Flat tummy continues to decline due to impact of GLP - 1s. Core supplement group is relatively strong but TV advertising is key for same store growth.

Risks & headwinds

  • International macro volatility: Uncertainty in UAE and Turkey led to license agreement termination. - Impact of GLP - 1s: Flat tummy weight loss business heavily impacted by GLP - 1s, strategic decision needed for flat tummy in near future.

Analyst Q&A

Q: On your comments on the RTD, year - to - date being better than all of last year, what kept that from being a lot higher in the fourth quarter?

A: Just raised money to build inventory in August, majority of RTD inventory received in - house in December.

Q: Looking at some of the other lines, was flat tummy up compared to third quarter?

A: Flat tummy continues to decline, impacted by GLP - 1s, strategic decision on flat tummy in near future.

Q: On the core supplement group, what's going on there?

A: Core supplement group is relatively strong, added key retailers like Kroger, but TV advertising key for same store growth.

Q: Outlook on gross margin with one - time things behind you?

A: Anticipate gross margin to maintain its current level or increase, looking at it normalized.

Q: Any other changes to go - to - market strategy on the RTD?

A: Sales cycle driven by planograms, expect Costco and BJ's Roadshows coming up.

Q: Recently formed subsidiary in Mexico, are there other international markets to create subsidiary?

A: No, currently no other plans on opening international markets directly at this time, focus on executing initiatives in 2026 in Mexico and other areas

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026